7-Arylidenenaltrexones as selective δ1 opioid receptor antagonists

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A series of 7-arylidinenaltrexones (2a-m) related to the prototypical δ1-selective antagonist, 7-benzylidenenaltrexone 1 (BNTX), have been synthesized in an effort to develop more selective ligands. Testing in smooth muscle preparations revealed that members of the series exhibited varying degrees of selectively for δ receptors, with the o-methoxy (2e) and o- chloro (2j) congeners being most potent and most selective (Ke ~ 0.8 nm). Evaluation of 1, 2e, and 2f sc in mice using the tail-flick procedure indicated that they are selective δ1 opioid receptor antagonists in the lower dose range. At high doses these ligands, including BNTX, exhibited decreased δ1 selectivity due to increases in the ED50 ratios of [D- Ser2,Leu5]enkephalin-Thr6 and morphine. It is concluded that 2e and 2f possess in vivo selectivity similar to that of BNTX, but are less potent as δ1 antagonists.

Original languageEnglish (US)
Pages (from-to)4177-4180
Number of pages4
JournalJournal of Medicinal Chemistry
Volume41
Issue number21
DOIs
StatePublished - Oct 8 1998

Fingerprint

Narcotic Antagonists
Ligands
Enkephalins
Morphine
Smooth Muscle
Muscle
Tail
Testing
7-benzylidenenaltrexone

Cite this

7-Arylidenenaltrexones as selective δ1 opioid receptor antagonists. / Ohkawa, S.; Portoghese, Philip S.

In: Journal of Medicinal Chemistry, Vol. 41, No. 21, 08.10.1998, p. 4177-4180.

Research output: Contribution to journalArticle

@article{0fc8d8bbf7bb4ea1afcffa7f73f698a7,
title = "7-Arylidenenaltrexones as selective δ1 opioid receptor antagonists",
abstract = "A series of 7-arylidinenaltrexones (2a-m) related to the prototypical δ1-selective antagonist, 7-benzylidenenaltrexone 1 (BNTX), have been synthesized in an effort to develop more selective ligands. Testing in smooth muscle preparations revealed that members of the series exhibited varying degrees of selectively for δ receptors, with the o-methoxy (2e) and o- chloro (2j) congeners being most potent and most selective (Ke ~ 0.8 nm). Evaluation of 1, 2e, and 2f sc in mice using the tail-flick procedure indicated that they are selective δ1 opioid receptor antagonists in the lower dose range. At high doses these ligands, including BNTX, exhibited decreased δ1 selectivity due to increases in the ED50 ratios of [D- Ser2,Leu5]enkephalin-Thr6 and morphine. It is concluded that 2e and 2f possess in vivo selectivity similar to that of BNTX, but are less potent as δ1 antagonists.",
author = "S. Ohkawa and Portoghese, {Philip S}",
year = "1998",
month = "10",
day = "8",
doi = "10.1021/jm980384s",
language = "English (US)",
volume = "41",
pages = "4177--4180",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "21",

}

TY - JOUR

T1 - 7-Arylidenenaltrexones as selective δ1 opioid receptor antagonists

AU - Ohkawa, S.

AU - Portoghese, Philip S

PY - 1998/10/8

Y1 - 1998/10/8

N2 - A series of 7-arylidinenaltrexones (2a-m) related to the prototypical δ1-selective antagonist, 7-benzylidenenaltrexone 1 (BNTX), have been synthesized in an effort to develop more selective ligands. Testing in smooth muscle preparations revealed that members of the series exhibited varying degrees of selectively for δ receptors, with the o-methoxy (2e) and o- chloro (2j) congeners being most potent and most selective (Ke ~ 0.8 nm). Evaluation of 1, 2e, and 2f sc in mice using the tail-flick procedure indicated that they are selective δ1 opioid receptor antagonists in the lower dose range. At high doses these ligands, including BNTX, exhibited decreased δ1 selectivity due to increases in the ED50 ratios of [D- Ser2,Leu5]enkephalin-Thr6 and morphine. It is concluded that 2e and 2f possess in vivo selectivity similar to that of BNTX, but are less potent as δ1 antagonists.

AB - A series of 7-arylidinenaltrexones (2a-m) related to the prototypical δ1-selective antagonist, 7-benzylidenenaltrexone 1 (BNTX), have been synthesized in an effort to develop more selective ligands. Testing in smooth muscle preparations revealed that members of the series exhibited varying degrees of selectively for δ receptors, with the o-methoxy (2e) and o- chloro (2j) congeners being most potent and most selective (Ke ~ 0.8 nm). Evaluation of 1, 2e, and 2f sc in mice using the tail-flick procedure indicated that they are selective δ1 opioid receptor antagonists in the lower dose range. At high doses these ligands, including BNTX, exhibited decreased δ1 selectivity due to increases in the ED50 ratios of [D- Ser2,Leu5]enkephalin-Thr6 and morphine. It is concluded that 2e and 2f possess in vivo selectivity similar to that of BNTX, but are less potent as δ1 antagonists.

UR - http://www.scopus.com/inward/record.url?scp=0032497596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032497596&partnerID=8YFLogxK

U2 - 10.1021/jm980384s

DO - 10.1021/jm980384s

M3 - Article

VL - 41

SP - 4177

EP - 4180

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 21

ER -